Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2010 by Novagali Pharma.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Novagali Pharma
ClinicalTrials.gov Identifier:
NCT00665106
First received: April 22, 2008
Last updated: July 15, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)